Know Labs responds to commencement of NYSE proceedings to delist

Know Labs (KNW) announced it is working on certain curative actions to regain compliance to maintain its listing and appeal the NYSE’s determination to delist its common stock to the Listings Qualifications Panel of the Exchange. The company’s stock will be suspended from trading on the NYSE American during this time. NYSE Regulation is commencing delisting proceedings in connection with its determination, announced, that the company is no longer suitable for listing pursuant to Section 1003 of the NYSE American Company Guide due to the bid price falling under 10c.